The Cooper Companies, Inc.
COO
Rang in aandelen
#1886
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Aandeelprijs
$59.03
Marktkapitalisatie
$11.23B
Verandering (1 dag)
1.50%
Verandering (1 jaar)
-21.28%
Land
US
Handel The Cooper Companies, Inc. (COO)
Categorie
Healthcare
P/S-ratio voor The Cooper Companies, Inc. (COO)
P/S-ratio op October 2026 TTM: 2.53
Volgens de meest recente financiële rapporten en aandelenkoers van The Cooper Companies, Inc. is de huidige P/S-ratio (TTM) 2.53. Eind 2024 had het bedrijf een P/S-ratio van 5.35.
P/S-ratiohistoriek voor The Cooper Companies, Inc. van 2000 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 2.53 | -26.13% |
| 2025 | 3.42 | -36.08% |
| 2024 | 5.35 | 24.45% |
| 2023 | 4.29 | 5.42% |
| 2022 | 4.07 | 128.95% |
| 2021 | 1.78 | 10.46% |
| 2020 | 1.61 | 19.18% |
| 2019 | 1.35 | 7.97% |
| 2018 | 1.25 | -8.82% |
| 2017 | 1.37 | 26.51% |
| 2016 | 1.09 | 5.57% |
| 2015 | 1.03 | -10.32% |
| 2014 | 1.15 | 15.90% |
| 2013 | 0.99 | 24.29% |
| 2012 | 0.80 | 30.27% |
| 2011 | 0.61 | 25.45% |
| 2010 | 0.49 | 66.35% |
| 2009 | 0.29 | 67.83% |
| 2008 | 0.17 | -64.68% |
| 2007 | 0.49 | -33.89% |
| 2006 | 0.75 | -15.15% |
| 2005 | 0.88 | -23.62% |
| 2004 | 1.15 | 39.95% |
| 2003 | 0.82 | 28.17% |
| 2002 | 0.64 | -15.35% |
| 2001 | 0.76 | 18.08% |
| 2000 | 0.64 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| 13.45 | 432.59% |
US
|
|
| 2.32 | -8.00% |
FR
|
|
| - | - |
JP
|
|
| 2.47 | -2.26% |
US
|
|
| - | - |
CH
|
